Cite

HARVARD Citation

    Mo, D. et al. (2023). Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer. Journal of clinical oncology. 41 (9), p. 1790. [Online]. 
  
Back to record